Nov 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2023 Sep 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.48 5.64 9.73
(-2.7 pct) (+31.0 pct) (+19.8 pct)
Operating 409 mln 1.38 487 mln
(-70.3 pct) (+96.1 pct) (-64.1 pct)
Recurring 548 mln 1.53 339 mln
(-64.1 pct) (+126.9 pct) (-74.8 pct)
Net 321 mln 972 mln 201 mln
(-67.0 pct) (+159.0 pct) (-75.2 pct)
EPS 41.11 yen 146.42 yen 25.72 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T